Order Article Reprints

Mohammed AA, Abo El-Matty DM, Abd ElSalam EA, Hussein MA, Hafez W, Ibrahim SA, Shaheen EAH, Awad EA, Osman MA, Abd El-Raouf MS, et al. Evaluating the Feasibility of Pro-Neurotensin and 25-Hydroxyvitamin D3 as Possible Indicators for Type 2 Diabetes Mellitus and Its Complications. Healthcare. 2023; 11(8):1088. https://doi.org/10.3390/healthcare11081088

Mohammed, Amal A., Dina M. Abo El-Matty, Esraa A. Abd ElSalam, Mona A. Hussein, Wael Hafez, Sharehan A. Ibrahim, Eman A. H. Shaheen, Eman A. Awad, Marwa A. Osman, Marwa S. Abd El-Raouf, and et al. 2023. "Evaluating the Feasibility of Pro-Neurotensin and 25-Hydroxyvitamin D3 as Possible Indicators for Type 2 Diabetes Mellitus and Its Complications" Healthcare 11, no. 8: 1088. https://doi.org/10.3390/healthcare11081088

Mohammed, A. A., Abo El-Matty, D. M., Abd ElSalam, E. A., Hussein, M. A., Hafez, W., Ibrahim, S. A., Shaheen, E. A. H., Awad, E. A., Osman, M. A., Abd El-Raouf, M. S., Saed, S. M., El-Amir, R. Y., Ghaith, D., Al Anouti, F., & Wahba, A. S. (2023). Evaluating the Feasibility of Pro-Neurotensin and 25-Hydroxyvitamin D3 as Possible Indicators for Type 2 Diabetes Mellitus and Its Complications. Healthcare, 11(8), 1088. https://doi.org/10.3390/healthcare11081088